Live Feed

AUSTIN, Minn., Oct. 12, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced Holly LaVallie is re-joining the company as vice president of marketing excellence.In her new role, LaVallie will lead the development and execution of enterprise marketing capabilities designed to support brand growth across the company's Retail, Foodservice and International businesses. Her responsibilities include brand strategy and experience, design and content, media and agency management, marketing technology, marketing training and marketing effectiveness."We are thrilled to welcome Holly back to Hormel Foods," John Ghingo, president and chief e

ANDOVER, Mass., Oct. 12, 2026 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ:MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release third quarter 2026 financial results after market close on Wednesday, November 4, 2026. A conference call with management will be held on Thursday, November 5, 2026, at 8:30 a.m. (Eastern Time). A live and archived webcast of the call can be accessed on the company’s website at https://investor.mks.com/, or by registering as a Participant by clicking here. We encourage participants to register at least 15 minutes prior to the start of the call. About MKS Inc.MKS Inc. (NASDAQ:MKSI) enables technologies

PLEASANTON, Calif., Oct. 12, 2026 /PRNewswire/ -- Simpson Manufacturing Co., Inc. (the "Company") (NYSE:SSD), an industry leader in engineered structural connectors and building solutions, announced today that it will report its financial results for the third quarter ended September 30, 2026, on Monday, October 26, 2026, at 4:15 p.m. Eastern Time. Michael Olosky, Simpson's President and Chief Executive Officer, and Matt Dunn, Chief Financial Officer and Treasurer, will host a conference call that same day at 5:00 p.m. Eastern Time. The call will be broadcast live over the Internet hosted on the Investor Relations section of the Company's website at ir.simpsonmfg.com.Simpson Manufacturing Co

PITTSBURGH, Oct. 12, 2026 /PRNewswire/ -- Federated Hermes Premier Municipal Income Fund (NYSE:FMN) has declared a dividend. The fund seeks to provide investors with current dividend income that is exempt from regular federal income tax. In addition, this fund features income exempt from the federal alternative minimum tax (AMT).Tax-Free Dividend Per ShareRecord Date:                  Oct. 23, 2026      Ex-Dividend Date:         Oct. 23, 2026Payable Date:                 Nov. 2, 2026 Amount          Change From Previous Month$0.0450                 $0.0000Investors can view additional portfolio information in the Products section of FederatedHermes.com.Federated Hermes, Inc. (NYSE:FHI) is a

Review of Strategic Alternatives to Maximize Stockholder Value Remains Ongoing Xponential Fitness, Inc. (NYSE:XPOF) ("Xponential" or the "Company"), one of the leading global franchisors of boutique health and wellness brands, today announced that the Company’s Board of Directors (the "Board") has adopted a limited-duration stockholder rights plan (the "Rights Plan"). As previously announced, the Company’s Board has initiated a review of strategic alternatives to maximize stockholder value. The review remains ongoing and is being led by the Board’s independent directors, with Jefferies serving as financial advisor. The Board, in consultation with its advisors, unanimously adopted the

The announcements reflect the Board of Trustees’ continued focus on seeking to enhance shareholder value, supporting the Fund's market valuation, and providing attractive cash distributions while maintaining flexibility to pursue the Fund's long-term investment objectives. Share Repurchase Program The Fund's Board of Trustees has authorized the implementation of a share repurchase program designed to seek to enhance shareholder value and provide additional support for the Fund's market price. In accordance with the program's trading plan, repurchases are expected to commence following an initial 30-day cooling-off period. Under the program, the Fund may from time to time repurchase sh

WOOD DALE, Ill., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Power Solutions International, Inc. (NASDAQ:PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, plans to conduct a conference call to discuss its third quarter 2026 results and business outlook on Thursday, November 5, 2026, at 5:00 p.m. Eastern time. After the close of the market on November 5 and prior to the conference call, Power Solutions International ("PSI") will issue a copy of the earnings press release via Globe Newswire. The press release may also be viewed on PSI’s website at https://investors.psiengines.com/press-releases. To listen to the conference call, please regist

Leerink Partners initiated coverage of Vera Therapeutics with a rating of Market Perform and set a new price target of $34.00

TD Cowen initiated coverage of TeraWulf with a rating of Buy and set a new price target of $21.00

UBS initiated coverage of Tectonic Therapeutic with a rating of Neutral and set a new price target of $26.00

UBS initiated coverage of Spyre Therapeutics with a rating of Buy and set a new price target of $120.00

UBS initiated coverage of Shattuck Labs with a rating of Buy and set a new price target of $17.00

Evercore ISI initiated coverage of Robinhood Markets with a rating of Outperform and set a new price target of $130.00

BTIG Research initiated coverage of Quoin Pharmaceuticals with a rating of Buy and set a new price target of $14.00

Leerink Partners initiated coverage of Q32 Bio with a rating of Outperform and set a new price target of $40.00

UBS initiated coverage of Protagonist Therapeutics with a rating of Buy and set a new price target of $184.00

UBS initiated coverage of Ocular Therapeutix with a rating of Buy and set a new price target of $14.00

UBS initiated coverage of Nektar Therapeutics with a rating of Neutral and set a new price target of $53.00

Leerink Partners initiated coverage of Nektar Therapeutics with a rating of Outperform and set a new price target of $130.00

Jefferies initiated coverage of MiniMed with a rating of Hold and set a new price target of $22.00